On November 5, Cognex fell 5.96% Overnight, trading at $49.9, with turnover of $6144.55.
The move followed the company’s latest quarterly results, after which investors appeared to focus on the durability of revenue recovery, margin improvement, and the pace of new-product commercialization, even though management raised full-year guidance.
For fiscal Q3, adjusted EPS was $0.53 versus $0.52 expected, while revenue rose to $313.4 million from $276.9 million a year earlier, roughly in line with consensus near $313.6 million. Cognex guided Q4 adjusted EPS to $0.37-$0.41 and revenue to $270 million-$290 million, versus consensus around $0.39 and $273.4 million. The company also lifted full-year adjusted EPS guidance to $1.68-$1.72 from $1.64-$1.68 and revenue guidance to $1.14 billion-$1.16 billion from $1.13 billion-$1.15 billion. Recent strategic updates include the $500 million cash acquisition of RealSense and the launch of the In-Sight 1750 wafer identification system.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments